Home > Cashflow Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Cash Flow from Financing Activities

    Back to Cashflow Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Cash Flow from Financing Activities ₹-15 Cr₹35 Cr₹8.29 Cr₹4.67 Cr₹-2.41 Cr

What is the latest Cash Flow from Financing Activities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Cash Flow from Financing Activities ratio of SYNCOM FORMULATIONS (INDIA) is ₹-15 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-15 Cr
Mar2023₹35 Cr
Mar2022₹8.29 Cr
Mar2017₹4.67 Cr
Mar2016₹-2.41 Cr

How is Cash Flow from Financing Activities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-15 Cr
Negative
Mar2023 ₹35 Cr
321.95
Mar2022 ₹8.29 Cr
77.66
Mar2017 ₹4.67 Cr
Positive
Mar2016 ₹-2.41 Cr -

Compare Cash Flow from Financing Activities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,802.0 Cr -10% -2.7% 48.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,249.0 Cr -1.3% -3.3% 8.3% Stock Analytics
DIVIS LABORATORIES ₹174,940.0 Cr -1.5% 0.8% 42.3% Stock Analytics
CIPLA ₹121,197.0 Cr -1.7% 2.3% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,618.0 Cr -1.6% 8.4% 10.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,250.0 Cr -3.3% -1.4% 9.8% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-10%

-2.7%

48.3%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses